NN

Ngariyanbam Nganthoi Chanu

Active Director Director DIN 11199642
DIN 11199642 First appointment Jul 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Ngariyanbam Nganthoi Chanu

Data last updated:

Ngariyanbam Nganthoi Chanu is a Director at Pluton Pharmaceutical Private Limited (since 2025).

DIN 11199642
Primary Designation Director
First Appointment 17 Jul 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Jul 20252025Active

Board colleagues of Ngariyanbam Nganthoi Chanu

NameDINCompanyDesignation
Ratika Ngariyanbam11199641Pluton Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Pluton Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Ngariyanbam Nganthoi Chanu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ngariyanbam Nganthoi Chanu

Ngariyanbam Nganthoi Chanu currently holds 1 directorship: Pluton Pharmaceutical Private Limited (Director, since 17 Jul 2025).

Ngariyanbam Nganthoi Chanu was first appointed on 17 Jul 2025 as Director at Pluton Pharmaceutical Private Limited.

The current boards of Ngariyanbam Nganthoi Chanu's companies include Ratika Ngariyanbam (Pluton Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available